Kidney stress study reveals Finerenone's inner workings
NCT ID NCT06244758
First seen Apr 28, 2026 · Last updated Apr 29, 2026 · Updated 1 time
Summary
This study looked at how the drug finerenone affects blood flow and oxidative stress in the kidneys of adults with type 2 diabetes. Researchers measured changes in kidney function and stress levels after treatment compared to a placebo. The goal was to understand how finerenone works, not to test a cure or symptom relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE2DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Research Center Erlangen, Department of Nephrology and Hypertension, University Hospital Erlangen
Erlangen, Germany
Conditions
Explore the condition pages connected to this study.